ORLANDO — An ethanol-free protocol for pancreatic cyst ablation followed by a combined paclitaxel and gemcitabine regimen for pancreatic neoplasia was effective and led to significant reductions in adverse events, according to research presented at the World Congress of Gastroenterology at ACG 2017.

“This is important because significantly improving the risk profile of this procedure, while preserving its efficacy, increases the attractiveness of this therapeutic option for patients with precancerous-type pancreatic cysts,” Matthew T. Moyer, MD, MS, of Penn State University Milton S. Hershey Medical Center, said during his presentation.